A young man with biventricular dysfunction and severe malperfusion to multiple organs is put on ECMO and Impella support. Despite Impella malfunction and subsequent stroke, he recovered to undergo heart-kidney transplant.
PDE-5 Inhibitors May Benefit Patients After Centrifugal-Flow LVAD Implant
If the findings of a new retrospective study are confirmed in a randomized controlled trial, phosphodiesterase-5 inhibitors could become standard of care in this setting.
CABG Is Possible for Patients With Heart Failure, With Appropriate Precautions
Our heart surgeons share advice on how to avoid postcardiotomy shock and help ensure success with coronary bypass in patients with left ventricular failure due to ischemic cardiomyopathy.
Acute MI Complicated by Cardiogenic Shock: New AHA Statement Pinpoints Best Practices
Enthusiasm for the use of temporary hemodynamic support must be tempered by the lack of randomized evidence of a mortality benefit in this setting.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Timely Referral for Transplant or LVAD Is Critical to Heart Failure Outcomes
A new JACC statement makes the case for earlier referral of patients with advanced heart failure. Our experts review the recommendations and the rationale behind them.
Mechanical Circulatory Support in COVID-19: When to Consider, What to Expect
ECMO and other forms of mechanical circulatory support have a role in cases involving either respiratory failure or cardiac failure, but generally not both. An expert surgeon reviews management strategies.
Meet Our New Heart Failure Section Head, Dr. Jerry Estep
The national PI of the ROADMAP trial shares his passion for VADs, current research projects that excite him and why he made a mid-career move to Cleveland Clinic.
What’s on the Horizon in Heart Failure Care and LVAD Technology?
Our experts share eight trends and developments that excite them most in mechanical circulatory support and beyond.
In LVAD Patients with Atrial Arrhythmias, Rhythm Control Offers Little Benefit
As the use of LVADs for destination therapy grows, a new study offers the first guidance on whether aggressive treatment for atrial arrhythmias makes a difference in this setting.